Literature DB >> 24372222

Essential hypertension, cerebral white matter pathology and ischemic stroke.

C Sierra1.   

Abstract

Stroke is one of the most-frequent causes of death and the first cause of disability worldwide. Different mechanisms are related to the pathogenesis of stroke, involving multiple biological systems, which are often inter-connected. Besides age, hypertension is the most important risk factor for stroke and may also predispose to the development of more subtle cerebral damage based on arteriolar narrowing or pathological microvascular changes. Age and high blood pressure are responsible for silent structural and functional cerebral changes leading to white matter lesions and cognitive impairment. The clinical significance and pathological substrate of white matter lesions are not fully understood. Hypertensive patients have more white matter lesions, which are an important prognostic factor for the development of stroke, cognitive impairment, dementia and death, than normotensive people. Over the past 10 years, strong evidence has emerged that cerebral white matter lesions in hypertensive patients should be considered a silent early marker of brain damage. The mechanisms that would explain all these relationships remain to be elucidated, but available data suggest that arteriosclerosis of the penetrating brain vessels is the main factor in the pathogenesis of ischemic white matter lesions.

Entities:  

Mesh:

Year:  2014        PMID: 24372222     DOI: 10.2174/0929867321666131227155140

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  6 in total

1.  Neurocognition in treatment-resistant hypertension: profile and associations with cardiovascular biomarkers.

Authors:  Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Stephanie M Mabe; Jeanne E Schwartz; Forgive Avorgbedor; Andrew Sherwood
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

2.  ABCA1/ApoE/HDL Pathway Mediates GW3965-Induced Neurorestoration After Stroke.

Authors:  Xu Cui; Michael Chopp; Zhenggang Zhang; Rongwen Li; Alex Zacharek; Julie Landschoot-Ward; Poornima Venkat; Jieli Chen
Journal:  Stroke       Date:  2016-12-27       Impact factor: 7.914

Review 3.  Neurovascular dysfunctions in hypertensive disorders of pregnancy.

Authors:  Olayemi K Ijomone; Itohan R Osahon; Comfort O A Okoh; Grace T Akingbade; Omamuyovwi M Ijomone
Journal:  Metab Brain Dis       Date:  2021-03-11       Impact factor: 3.584

4.  Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis.

Authors:  Jianping Hu; Yong Xu; Zemin He; Hui Zhang; Xiaoqing Lian; Tiantian Zhu; Caihong Liang; Jun Li
Journal:  Oncotarget       Date:  2017-11-29

5.  The safety and efficacy of tPA intravenous thrombolysis for treating acute ischemic stroke patients with a history of cerebral hemorrhage.

Authors:  Guang-Jian Zhao; Zi-Ran Wang; Fan-Zhen Lin; Yan-Sen Cui; Shun-Liang Xu
Journal:  Braz J Med Biol Res       Date:  2019-01-24       Impact factor: 2.590

6.  Cerebral Small Vessel Disease Associated with Subclinical Vascular Damage Indicators in Asymptomatic Hypertensive Patients.

Authors:  Zenaida Milagros Hernández-Díaz; Marisol Peña-Sánchez; Alina González-Quevedo Monteagudo; Sergio González-García; Paula Andrea Arias-Cadena; Marta Brown-Martínez; Mélany Betancourt-Loza; Anay Cordero-Eiriz
Journal:  Behav Sci (Basel)       Date:  2019-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.